Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
about
The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosisOn the potential role of glutamate transport in mental fatigueFatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain StimulationA practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosisMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic reviewThe Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueIs there a cognitive signature for MS-related fatigue?Fatigue in multiple sclerosis: mechanisms, evaluation, and treatmentNeutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosisNatalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life settingThe representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis.Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?Is personality profile a relevant determinant of fatigue in multiple sclerosis?Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internetThe many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersTreatment of fatigue in multiple sclerosis patients: a neurocognitive approach.Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controlsAndrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study.Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnographyDepression and immunity: inflammation and depressive symptoms in multiple sclerosis.Origin of fatigue in multiple sclerosis: review of the literature.Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis.The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programmeAssociation of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.Prospective association between C-reactive protein and fatigue in the coronary artery risk development in young adults study.Fatigue: an important feature of late-onset Pompe disease.Biomarkers for chronic fatigue.Multiple sclerosis-associated fatigue.A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.Fatigue in Multiple Sclerosis: Misconceptions and Future Research DirectionsInosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.A mechanism for sickness sleep: lessons from invertebrates.Multiple sclerosis related fatigue.Biological outcome measurements for behavioral interventions in multiple sclerosis.Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β.
P2860
Q21245612-5AE5EC35-29FB-4B2C-AFB6-1D4EEC164C18Q24799096-4D31F091-8488-4642-85DC-0570CEF61ABDQ26773166-D10D75AE-7A6B-4A7C-A75A-DBC4BC1F27EDQ26776231-54735F8F-B62E-491C-A801-35FD3EA3CA09Q26998412-2C4771E3-258D-49F3-BFCB-E44E913AB52AQ27007478-5862A02E-6207-4AEF-A2F6-0AA52E6860E6Q28073849-712C54D5-0D93-4D44-8B36-BE05C9C532ADQ30855268-1053342F-7F61-4D18-83BA-D6BBB3FFB0C0Q34021881-5557E06A-8D82-4EE0-864C-62D4C6595F38Q34636829-B5D9D9A6-957E-4711-82ED-9632D4CE84CEQ34650470-B26D8C19-CC7B-40EC-BD4D-0618514F9D62Q34677503-CF3093FA-2F45-4104-B271-2A3DB30EA575Q34755512-C43AF8B3-3476-47CC-AA40-5D1B9BCE9895Q35036908-CDB625E3-ABED-4BB2-B918-8B2AFF13A890Q35047839-E1FA38C5-322F-4D65-99B1-16067303B834Q35059951-1D8B486A-932C-4D66-A8BC-8C0A77E56D4AQ35097889-EB0F8A97-B2D3-4F27-B7D5-0AE6AC27188AQ35246024-371ED97B-EBFA-4844-82E8-96B3CA3F685CQ35390868-9A81EC0A-6CE1-4E22-A190-DCEF38431341Q35666632-28ED30DB-7A1B-4662-BCAF-D367957463F3Q36026962-AC4FB41F-08C7-45F5-BC92-8803B4DDBA41Q36226201-2F066018-FD91-420C-AD45-1700EDD2F982Q36515790-320A7E11-EE5F-4BFF-B730-F9C74F41F5B2Q36764298-C41F2B71-5241-4D3F-BE9A-6F9636E06781Q36780439-4CD4685C-BC91-43DC-B4D5-5E879662B4ADQ36889694-51FE786D-0018-47FC-8E57-8EA903BCBBF2Q37116754-558977BF-DA2D-4F13-802A-E4A2CD5B1DB0Q37285028-72028D24-8D58-4260-B57D-11797F3DB7CDQ37389736-FF34E2D9-F8BC-4716-BF8C-720047BEE45FQ37425960-D55BAE36-EF1B-477F-8C30-0943C8CDA61AQ37730322-9F3857C7-6685-4CC4-9CD4-7E7BF79DDD2AQ37785555-6532C9A0-183A-4EA3-8BAC-E86E202646B7Q38020430-92D73F03-5CCB-4879-ACE4-E318771C8141Q38322773-79D435D8-7DB7-4CEC-BAEC-5AA03FFF5183Q38830626-74C4005B-A5B9-4F05-8B34-DF282601707DQ38873695-C5F2CAAC-E5C3-4BE4-B396-7178948F90C8Q39060211-F51E3DA4-9EA2-4784-A89D-133FA80B4F30Q42765096-713E9746-A00F-4D88-9B4E-4CD11FC6F149Q42789516-F9B3C8C2-911B-496F-B604-9CB106BAA8A2Q44072358-AEE35646-DC24-484C-AC8A-137C5F4AAE5E
P2860
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@en
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@nl
type
label
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@en
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@nl
prefLabel
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@en
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@nl
P2093
P2860
P1476
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
@en
P2093
Irene Bihler
Klaus V Toyka
M Gottschalk
Peter Flachenecker
Peter Rieckmann
P2860
P304
P356
10.1191/1352458504MS991OA
P577
2004-04-01T00:00:00Z